Apotex Health Corp faces a challenging trading session as shares drop significantly.
Apotex Health Corp (APTX.TO) is having a tough day on the TSX, with its stock sliding by 3.97% to close at CA$35.58. Investors are closely watching the reasons behind this downturn amid recent corporate developments.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeAdvertisement
Market cap
$8.62B
P/E
22.8x
52W high
$40.18
52W low
$26.05
1W change
-0.54%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 11.3% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.24
+11.3% Upside
Current Price
C$37.05
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
49.2%
Annualized
90-Day Vol
51.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$44.29
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$39.32 | C$33.19 – C$46.59 |
| 60 trading days | C$41.73 | C$32.83 – C$53.05 |
| 90 trading days | C$44.29 | C$33.01 – C$59.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Despite some recent positive news about credit agreements and public offerings, Apotex's stock performance today raises concerns about investor sentiment and market confidence.
Stock Down 3.97% Today
Apotex's market cap now stands at CA$8.62 billion, showing that there is still significant investor interest despite today's pullback.
Bull case
The company recently received an investment-grade issuer rating. This could lower borrowing costs and improve operational flexibility over time.
Bear case
Today's decline highlights potential concerns among investors about whether Apotex can sustain its recent gains and how the market feels about healthcare stocks overall.
Market Reaction
Advertisement
The 3.97% drop in Apotex's stock today has caught investors' attention, especially given the company's recent achievements, like securing an investment-grade rating. This decline might reflect broader market trends or specific worries about the company's future performance.
Recent Developments
Apotex recently announced an amended credit agreement, which is expected to enhance its operational flexibility. However, the lack of an immediate positive market reaction suggests that investors may be weighing potential risks against these developments.
Looking Ahead
Investors will be eager to see how Apotex navigates this downturn and whether upcoming financial reports can restore confidence in its stock. The company’s future performance will depend on its ability to leverage recent improvements in its credit rating and operational capabilities.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
